Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes.
Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year.
Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all.
See our community guidelines here: https://www.servier.us/community-guidelines
To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us
Home page | Servier US
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Fred Hutch Research Services | Other 16 May 2022 | | ||
Timmerman Report Online Audio and Video Media | Other 18 Jan 2020 | | ||
Valence Labs biotech, deeptech, Biotechnology Research | Not capitalistic Partnership Not event 24 Mar 2021 | | ||
Amadix biotech, deeptech, Biotechnology Research | Other 25 Jan 2022 | | ||
Festival de la Communication Santé healthtech, Wellness and Fitness Services | Other 26 Jan 2021 | |